Phase I Clinical Study of ZL-82 Tablets

Conditions

• Rheumatoid Arthritis (RA)
• Inflammatory Bowel Disease - IBD1

Interventions

• DRUG: ZL-82 12.5mg
• DRUG: ZL-82 25mg
• DRUG: ZL-82 50mg
• DRUG: ZL-82 100mg
• DRUG: ZL-82 200mg
• DRUG: ZL-82 300mg
• DRUG: ZL-82 450mg
• DRUG: ZL-82 600mg
• DRUG: zL-82 placebo 12.5mg
• DRUG: ZL-82 placebo 25mg
• DRUG: ZL-82 placebo 50mg
• DRUG: ZL-82 placebo 100mg
• DRUG: ZL-82 placebo 200mg
• DRUG: ZL-82 placebo 300mg
• DRUG: ZL-82 placebo 450mg
• DRUG: ZL-82 placebo 600mg

Sponsor

Chengdu Zenitar Biomedical Technology Co., Ltd